MedPath

comparison of two radiotherapy regimens in spinal cord compression patients

Phase 3
Conditions
Health Condition 1: C348- Malignant neoplasm of overlappingsites of bronchus and lung
Registration Number
CTRI/2020/04/024707
Lead Sponsor
Dr Anil Tibdewal
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age > 18 years and <= 75 years

2.Pathologically proven lung malignancy

3.Patients with clinico â?? radiological diagnosis of MESCC

4.Willing and able to comply with all study requirements, including treatment; able to come for follow-up at regular intervals.

5.Patients able to come for at least first follow up

6.Patients who can provide signed written informed consent

Exclusion Criteria

1.Surgical intervention for treatment of MESCC

2.Previous irradiation over the involved spine segments

3.Patients with symptomatic brain metastases

4.Patients not willing and not able to come for follow up

5.Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the response rate of pain and ambulation (defined as improvement or no deterioration) between the two dose fractionation regimens namely 8 Gy in two fractions (ARM 1) with 20 Gy in 5 fractions (ARM 2) at 4 weeks (-1 week to +2 weeks) in metastatic epidural spinal cord compression of lung cancer patients.Timepoint: 4 weeks
Secondary Outcome Measures
NameTimeMethod
To compare response rates at 3 and 6 months <br/ ><br>To compare duration of response between two arms <br/ ><br>Incidence of Re-irradiation between two armsTimepoint: 3 and 6 months
© Copyright 2025. All Rights Reserved by MedPath